Tag:
GSK
Latest Headlines
Latest Headlines
Subpar clinical trials probed in India's review of regulation
Indian lawmakers and patient advocates charge that their regulator rubber-stamped drugs to be sold in the county without required clinical trials.
Pfizer, Roche, GSK said to be knocking heads with generics on EU drug tracking
A proposal by the European Union to require unique identifiers on drug packages to fight counterfeiting has sparked a fight between branded makers and generics companies.
HGS snubs $2.6B buyout offer from Benlysta partner GSK
Human Genome Sciences ($HGSI) is entertaining bids after rebuffing partner GlaxoSmithKline's ($GSK) $2.59 billion buyout overture.
FDA questions benefit of Merck and Ariad’s bone cancer drug
Merck ( $MRK ) and Ariad Pharmaceuticals ( $ARIA ) face a big test for their experimental cancer drug ridaforolimus next week. In briefing docs released today, FDA staffers questioned whether the drug should be approved given the slim survival benefits that it provides. That will be a central question for FDA advisers to consider at an advisory committee meeting slated for March 20.
GSK studies Chinese remedies to discover new drugs
Amid GlaxoSmithKline's ( $GSK ) major push to expand in China , the London-based drugmaker has located a new R&D unit in that country that will investigate traditional Chinese medicines. The move is
GSK deal chief hunts for 'hidden gems' to feed drug giant's pipeline
GlaxoSmithKline ( $GSK ) descended upon the big J.P. Morgan meeting in solid numbers this week as the U.K. drug giant scouted for a variety of deals with other companies in the biopharma arena. And Dow
FDA drug approvals soared in 2011, big year for GSK, J&J
Safety-conscious U.S. regulators have taken part of the blame for the drug industry's monumental problems, many of which center on an inability to bring enough new products to market. But the FDA can
GSK gets R&D grant that aims to protect U.K. jobs
Economic development officials in the U.K. appear determined to stem the loss of pharma jobs. Scottish Enterprise has awarded a £1.46 million research and development grant to GlaxoSmithKline (
AZ, GSK ask carmakers for directions amid pharma breakdown
As the pharmaceutical companies roll into the commercial equivalent of the breakdown lane, drugmakers are seeking advice from members of the auto industry that have tuned up their strategies multiple
Report: GSK closing in on deal with Boston PE group for OTC assets
A Boston private equity group has pulled ahead in a contest to scoop up consumer health products from GlaxoSmithKline ( $GSK ), with a final deal in the works that could be revealed by the companies
